Calendar Syngene International Limited
Equities
SYNGENE
INE398R01022
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
636.05 INR | +0.77% |
|
-2.61% | -25.91% |
06-16 | Syngene Gets Voluntary Action Indicated Classification from US FDA for Biocon Park Facility | MT |
06-16 | Syngene International Facility Cleared by US FDA with Zero Observations After Inspection | MT |
Chart calendar Syngene International Limited
205692c2988.yu5xKY0HMmig6IqnpRc0lbnnxoMtm-FUZQH-lZi0gSA.g6UpTM4zfCDivf_kz2B82My_kOhJ1ZJmIFbL3rX9zFmgiwNFoFBrHuKE3w~036a32cbe0c012111e85c556603fdc51
Upcoming events on Syngene International Limited
Past events on Syngene International Limited
Past dividends on Syngene International Limited
27/06/2024 | Annual 1.25 INR |
29/06/2023 | Annual 0.5 INR |
29/06/2023 | Bonus Payment 0.75 INR |
29/06/2022 | Annual 0.5 INR |
29/06/2022 | Bonus Payment 0.5 INR |
15/07/2019 | Annual 0.5 INR |
16/07/2018 | Annual 1 INR |
19/07/2017 | Annual 1 INR |
16/03/2016 | Interim Payment 1 INR |
Annual results
Fiscal Period | March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 26 042 25 629 1.61% | 31 929 31 232 2.23% | 34 886 35 962 -2.99% | 36 424 37 123 -1.88% | 39 178 | 45 615 |
EBITDA Million INR | Released Forecast Spread | 7 961 7 616 4.53% | 9 344 9 320 0.25% | 10 702 10 278 4.13% | 10 437 10 772 -3.11% | 10 219 | 12 999 |
EBIT Million INR | Released Forecast Spread | 4 864 4 898 -0.7% | 5 679 5 664 0.26% | 6 443 6 271 2.74% | 6 111 6 445 -5.18% | 5 702 | 8 141 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 4 844 4 874 -0.62% | 5 936 5 786 2.6% | 6 208 6 163 0.73% | 6 599 6 909 -4.49% | 5 687 | 7 935 |
Net income Million INR | Released Forecast Spread | 3 958 4 032 -1.84% | 4 644 4 566 1.71% | 5 100 4 787 6.55% | 4 962 5 116 -3.02% | 4 193 | 6 017 |
EPS INR | Released Forecast Spread | 9,82 10,2 -3.29% | 11,5 11,2 2.61% | 12,7 11,9 6.63% | 12,3 12,4 -0.61% | 11,1 | 15,3 |
Announcement Date | 27/04/22 | 26/04/23 | 24/04/24 | 23/04/25 |
Quarterly results
Fiscal Period | March | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 7 681 7 134 7.66% | 7 859 7 741 1.52% | 9 944 8 991 10.6% | 8 081 7 634 5.85% | 9 101 9 144 -0.47% | 8 535 8 964 -4.79% | 9 169 10 276 -10.77% | 7 897 8 067 -2.11% | 8 963 | 9 667 | 10 612 | 8 292 | 9 266 | 9 909 | 11 133 |
EBITDA Million INR | Released Forecast Spread | 2 165 2 070 4.59% | 2 466 2 337 5.54% | 3 141 2 869 9.49% | 2 119 2 181 -2.86% | 2 541 2 704 -6.02% | 2 439 2 676 -8.86% | 3 269 3 122 4.69% | 1 731 2 269 -23.71% | 2 423 | 2 932 | 3 555 | ||||
EBIT Million INR | Released Forecast Spread | 1 449 1 219 18.9% | 1 520 1 361 11.65% | 2 185 2 046 6.81% | 1 098 1 183 -7.22% | 1 495 1 670 -10.5% | 1 358 1 586 -14.36% | 2 158 2 090 3.26% | 662 714 -7.29% | 1 329 | 1 584 | 2 218 | 684 | 1 274 | 1 462 | 2 032 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 2 060 | ||||||||||||||
Net income Million INR | Released Forecast Spread | 1 020 961 6.18% | 1 097 1 134 -3.26% | 1 787 1 518 17.72% | 934 1 062 -12.05% | 1 165 1 285 -9.34% | 1 115 1 189 -6.22% | 1 886 1 559 20.95% | 757 1 053 -28.08% | 1 148 | 1 444 | 1 859 | ||||
EPS INR | Released Forecast Spread | 2,53 2,62 -3.51% | 2,71 2,81 -3.47% | 4,43 3,84 15.39% | 2,32 2,31 0.56% | 2,90 3,27 -11.26% | 2,77 2,95 -6.2% | 4,69 3,48 34.6% | 1,88 1,25 50.93% | 2,35 | 3,01 | 4,08 | ||||
Announcement Date | 19/10/22 | 23/01/23 | 26/04/23 | 26/07/23 | 17/10/23 | 25/01/24 | 24/04/24 | 24/07/24 | - | - | - | - | - | - | - |
22/07/2025 | ALKERMES PLC: Q2 2025 Earnings Release (Projected) |
22/07/2025 | ICON PUBLIC LIMITED COMPANY: Q2 2025 Earnings Release (Projected) |
22/07/2025 | SYNGENE INTERNATIONAL LIMITED: Q1 2026 Earnings Release (Projected) |
22/07/2025 | LONZA GROUP AG: Q2 2025 Earnings Release |
23/07/2025 21:01 | GALAPAGOS NV: Q2 2025 Earnings Release |
23/07/2025 | EUROFINS SCIENTIFIC SE: Q2 2025 Earnings Release |
24/07/2025 06:00 | BACHEM HOLDING AG: Q2 2025 Earnings Release |
24/07/2025 | PHARVARIS N.V.: Q2 2025 Earnings Release (Projected) |
25/07/2025 06:00 | BB BIOTECH AG: Q2 2025 Earnings Release |
27/07/2025 | MEDPACE HOLDINGS, INC.: Q2 2025 Earnings Release (Projected) |
Past sector events for Syngene International Limited
10/06/2025 08:20 | POLARIS GROUP: May 2025 Sales and Revenue Release |
29/05/2025 12:00 | IMMUNOVANT, INC.: Q4 2025 Earnings Release |
27/05/2025 | MESOBLAST LIMITED: Q3 2025 Earnings Release (Projected) |
22/05/2025 12:00 | REPLIMUNE GROUP, INC.: Q4 2025 Earnings Release |
21/05/2025 07:00 | BIOARCTIC AB: Q1 2025 Earnings Release |
20/05/2025 12:00 | CUREVAC N.V.: Q1 2025 Earnings Release |
14/05/2025 | GI INNOVATION, INC.: Q1 2025 Earnings Release |
14/05/2025 | GNI GROUP LTD.: Q1 2025 Earnings Release |
14/05/2025 21:32 | SS INNOVATIONS INTERNATIONAL, INC.: Q1 2025 Earnings Release |
14/05/2025 12:30 | ARBUTUS BIOPHARMA CORPORATION: Q1 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SYNGENE Stock
- Calendar Syngene International Limited
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition